Cytocom, Inc. Announces Plan to Adopt New Corporate Name “Statera BioPharma, Inc.”
By: Colorado BioScience Association Date: 09/03/2021
Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to change its corpor...
Learn MoreHeads Up Health Extends Seed Round to $2.25M Led by Innosphere Ventures
By: Colorado BioScience Association Date: 09/03/2021
Innosphere Ventures’ seed-stage venture capital fund has announced its second investment into Heads Up Health (Heads Up) which gives Heads Up the ability to close out their seed round at $2.25 millio...
Learn MoreCSURF announces the departure of Todd Headley, VP of Technology Transfer
By: Colorado BioScience Association Date: 09/02/2021
It is with mixed emotions that CSURF announces the departure of Todd Headley, Vice President of Technology Transfer. Todd’s contributions and impact at CSURF and Colorado State University have b...
Learn MoreSomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
By: Colorado BioScience Association Date: 09/01/2021
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it has completed its business combination with CM Life Sciences II, Inc. (Nasdaq: CMIIU), a special purpose acqu...
Learn MoreZalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa
By: Colorado BioScience Association Date: 08/31/2021
Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever (LF), today announced its contract with t...
Learn MorePharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine
By: Colorado BioScience Association Date: 08/25/2021
Vaccine delivered exclusively with the PharmaJet Needle-free System GOLDEN, Colo.- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila...
Learn MoreGolden-based BioIntelliSense ramps up with $45M in financing to scale vital-monitoring sticker
By: Colorado BioScience Association Date: 08/19/2021
The Golden-based company received FDA approval and insurance reimbursement approval for a remote monitoring wearable that can continuously collect vital signs data from a patient. Find out more in the...
Learn MoreEdgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Individuals with Becker Muscular Dystrophy (BMD)
By: Colorado BioScience Association Date: 08/16/2021
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, today announced t...
Learn MoreKromaTiD Appoints Nathan Wood as Chief Executive Officer
By: Colorado BioScience Association Date: 08/16/2021
KromaTiD, Inc. announces that Nathan Wood, will be joining as its Chief Executive Officer. Wood is a seasoned executive with thirty years of experience in the life science industry and is the for...
Learn MoreFitzsimons Innovation Community Accelerates Growth
By: Colorado BioScience Association Date: 08/12/2021
Breaks ground on first full-scale commercial manufacturing facility, for cell and gene therapy AURORA, Colo. (August 12, 2021) – Today, Fitzsimons Innovation Community breaks ground on its new bioscie...
Learn More